top of page


From Neigh to Yay: Balancing Empathetic Engagement and Boundaries in Challenging Conversations
Are you feeling the strain of high-maintenance clients, compassion fatigue, and relentless stress? Join us for a webinar tailored to address

Siddra Hines, DVM, PhD, DACVIM-LA
Aug 21, 20241 min read
48
2


Newly Available Horse-Side IgG Test Requires No Refrigeration
VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals.
Stilts Adams
Jan 16, 20231 min read
61
0


VMRD Releases New Feline Test for the Biomarker Serum Amyloid A (SAA)
VMRD, a leading veterinary diagnostics manufacturer, is pleased to announce the release of their new test, VMRD SAA for Feline.

Siddra Hines, DVM, PhD, DACVIM-LA
Feb 28, 20221 min read
27
0


Improving Foal Care with Serum Amyloid A (SAA) Testing
Foals are highly vulnerable and delicate compared to adult horses, making timely identification of disease particularly important for early
Stilts Adams
Feb 1, 20214 min read
101
0


Serum Amyloid A (SAA) Testing to Differentiate and Monitor Synovial Sepsis
Early and accurate detection of septic arthritis/synovitis is critical to minimize damage to cartilage and other structures that can ultimat

Siddra Hines, DVM, PhD, DACVIM-LA
Jul 1, 20203 min read
68
0


Independent External Validation of the VMRD Serum Amyloid A (SAA) Test
To build on the internal validation performed by VMRD, our Serum Amyloid A (SAA) test was independently evaluated by at UC Davis.

Siddra Hines, DVM, PhD, DACVIM-LA
Jul 1, 20202 min read
12
0


Unexpected Results and Confounding Factors in Serum Amyloid A (SAA) Testing
To avoid unexpected SAA results it is critical to understand basic SAA biology and interpret results in light of other clinical data.

Siddra Hines, DVM, PhD, DACVIM-LA
Mar 1, 20203 min read
12
0


Using Serum Amyloid A (SAA) Testing to Monitor Patients
The dynamic nature of SAA makes it an ideal marker for monitoring progression or resolution of illness, including response to treatment.

Siddra Hines, DVM, PhD, DACVIM-LA
Mar 1, 20204 min read
8
0
bottom of page